(Q46103524)

19 December 2017

title

TGF-beta/Smad pathway and BRAF mutation play different roles in circumscribed and infiltrative papillary thyroid carcinoma (English)

1 reference

19 December 2017

author

Catarina Eloy

1

1 reference

19 December 2017

Paula Soares

4

1 reference

19 December 2017

Manuel Sobrinho Simões

5

1 reference

19 December 2017

author name string

J Santos

2

1 reference

19 December 2017

J Cameselle-Teijeiro

3

1 reference

19 December 2017

language of work or name

1 reference

20 April 2012

1 reference

19 December 2017

published in

Virchows Archiv

1 reference

19 December 2017

volume

460

1 reference

19 December 2017

issue

6

1 reference

19 December 2017

page(s)

587-600

1 reference

19 December 2017

Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991.

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1234-Y

PAX8-PPARgamma rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1234-Y

Molecular pathology of well-differentiated thyroid carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1234-Y

Follicular, papillary, and "hybrid" carcinomas of the thyroid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1234-Y

Molecular genotyping of papillary thyroid carcinoma follicular variant according to its histological subtypes (encapsulated vs infiltrative) reveals distinct BRAF and RAS mutation patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1234-Y

Intratumoural lymph vessel density is related to presence of lymph node metastases and separates encapsulated from infiltrative papillary thyroid carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1234-Y

Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1234-Y

Molecular mechanisms involved in differentiated thyroid cancer invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1234-Y

Increased expression of Met protein is associated with up-regulation of hypoxia inducible factor-1 (HIF-1) in tumour cells in papillary carcinoma of the thyroid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1234-Y

Unique patterns of tumor growth related with the risk of lymph node metastasis in papillary thyroid carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1234-Y

Role of integrins in cell invasion and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1234-Y

Papillary carcinoma of the thyroid: hepatocyte growth factor (HGF) stimulates tumor cells to release chemokines active in recruiting dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1234-Y

In situ evidence of neoplastic cell phagocytosis by macrophages in papillary thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1234-Y

Increased density of tumor-associated macrophages is associated with decreased survival in advanced thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1234-Y

Transforming growth factor-beta 1 is a negative regulator for differentiated thyroid cancer: studies of growth, migration, invasion, and adhesion of cultured follicular and papillary thyroid cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1234-Y

The BRAFV600E oncogene induces transforming growth factor beta secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1234-Y

TGFbeta, activin and SMAD signalling in thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1234-Y

Transforming growth factor-beta1 and activin A generate antiproliferative signaling in thyroid cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1234-Y

Progression of BRAF-induced thyroid cancer is associated with epithelial-mesenchymal transition requiring concomitant MAP kinase and TGFβ signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1234-Y

TGF-beta signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1234-Y

New insights into TGF-beta-Smad signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1234-Y

Role of transforming growth factor Beta in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1234-Y

TGF-beta control of rat thyroid follicular cells differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1234-Y

Role of transforming growth factor beta in the regulation of thyroid function and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1234-Y

Expression of SMAD proteins, TGF-beta/activin signaling mediators, in human thyroid tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1234-Y

Expression of Smad4 and Smad7 in human thyroid follicular carcinoma cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1234-Y

Role of reduced expression of SMAD4 in papillary thyroid carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1234-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1234-Y

Reduction of invasive potential in K-ras-transformed thyroid cells by restoring of TGF-beta pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1234-Y

Role of Ras and Mapks in TGFbeta signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1234-Y

Acquired and naturally occurring resistance of thyroid follicular cells to the growth inhibitory action of transforming growth factor-beta 1 (TGF-beta 1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1234-Y

Lack of responsiveness to TGF-beta1 in a thyroid carcinoma cell line with functional type I and type II TGF-beta receptors and Smad proteins, suggests a novel mechanism for TGF-beta insensitivity in carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1234-Y

Conditional activation of RET/PTC3 and BRAFV600E in thyroid cells is associated with gene expression profiles that predict a preferential role of BRAF in extracellular matrix remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1234-Y

Transforming growth factor beta1 induces nuclear export of inhibitory Smad7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1234-Y

Encapsulated well-differentiated follicular-patterned thyroid carcinomas do not play a significant role in the fatality rates from thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1234-Y

BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1234-Y

Correlation Between Genetic Alterations and Microscopic Features, Clinical Manifestations, and Prognostic Characteristics of Thyroid Papillary Carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1234-Y

TGFB, TGFB Receptors, Ki-67, and p27(Kip)l Expression in Papillary Thyroid Carcinomas

21 January 2018

1 reference

12 December 2020

Epithelial rat thyroid cell clones, escaping from transforming growth factor beta negative growth control, are still inhibited by this factor in the ability to trap iodide.

1 reference

12 December 2020

Loss of cellular polarity/cohesiveness in the invasive front of papillary thyroid carcinoma, a novel predictor for lymph node metastasis; possible morphological indicator of epithelial mesenchymal transition

1 reference

12 December 2020

A complex pattern of mutations and abnormal splicing of Smad4 is present in thyroid tumours

1 reference

12 December 2020

Expression of transforming growth factor-beta1, activin A, and their receptors in thyroid follicle cells: negative regulation of thyrocyte growth and function

1 reference

12 December 2020

Immunocytochemically detectable TGF-beta associated with malignancy in thyroid epithelial neoplasia

1 reference

12 December 2020

TGF-beta 1 immunohistochemistry in goiter: comparison of patients with recurrence or no recurrence

1 reference

12 December 2020

The preeminence of growth pattern and invasiveness and the limited influence of BRAF and RAS mutations in the occurrence of papillary thyroid carcinoma lymph node metastases

1 reference

12 December 2020

Analysis of TGF-B and TGF-B-RII in Thyroid Neoplasms from the United States, Japan, and China

1 reference

12 December 2020

TGF-beta-induced apoptosis in human thyrocytes is mediated by p27kip1 reduction and is overridden in neoplastic thyrocytes by NF-kappaB activation

1 reference

12 December 2020

Pattern of expression of intermediate cytokeratin filaments in the thyroid gland: an immunohistochemical study of simple and stratified epithelial-type cytokeratins

1 reference

12 December 2020

ret/PTC expression may be associated with local invasion of thyroid papillary carcinoma

1 reference

12 December 2020

Immunohistochemical expression of galectin-3 in benign and malignant thyroid lesions

1 reference

12 December 2020

Dynamic changes in E-cadherin gene promoter methylation during metastatic progression in papillary thyroid cancer

1 reference

12 December 2020

The effects of transforming growth factor-beta on growth and differentiation of the continuous rat thyroid follicular cell line, FRTL-5

1 reference

12 December 2020

Expression of transforming growth factor beta1, beta2, and beta3 in multinodular goiters and differentiated thyroid carcinomas: a comparative study

1 reference

12 December 2020

Long-term results and prognostic factors in patients with differentiated thyroid carcinoma

1 reference

12 December 2020

Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients’ age but not with tumour aggressiveness

1 reference

12 December 2020

10.1007/S00428-012-1234-Y

Identifiers

DOI

1 reference

19 December 2017

1 reference

19 December 2017